BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37196903)

  • 1. Targeted long-term noninvasive treatment of choroidal neovascularization by biodegradable nanoparticles.
    Yao H; Xu H; Wu M; Lei W; Li L; Liu D; Wang Z; Ran H; Ma H; Zhou X
    Acta Biomater; 2023 Aug; 166():536-551. PubMed ID: 37196903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
    Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
    Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration.
    Leaderer D; Cashman SM; Kumar-Singh R
    Exp Eye Res; 2015 Nov; 140():171-178. PubMed ID: 26368850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.
    Feng L; Hu JH; Chen J; Xie X
    J Zhejiang Univ Sci B; 2018 Apr.; 19(4):327-332. PubMed ID: 29616508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.
    Gross N; Ranjbar M; Evers C; Hua J; Martin G; Schulze B; Michaelis U; Hansen LL; Agostini HT
    Mol Vis; 2013; 19():54-61. PubMed ID: 23335851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Noninvasive Treatment of Choroidal Neovascularization by Hybrid Cell-Membrane-Cloaked Biomimetic Nanoparticles.
    Li M; Xu Z; Zhang L; Cui M; Zhu M; Guo Y; Sun R; Han J; Song E; He Y; Su Y
    ACS Nano; 2021 Jun; 15(6):9808-9819. PubMed ID: 34037377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
    Steinle NC; Du W; Gibson A; Saroj N
    Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.
    Yan Z; Shi H; Zhu R; Li L; Qin B; Kang L; Chen H; Guan H
    Mol Vis; 2018; 24():83-93. PubMed ID: 29422766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD.
    Wei X; Zhang T; Yao Y; Zeng S; Li M; Xiang H; Zhao C; Cao G; Li M; Wan R; Yang P; Yang J
    Exp Eye Res; 2018 Mar; 168():2-11. PubMed ID: 29284110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End binding-3 inhibitor activates regenerative program in age-related macular degeneration.
    Lee Q; Chan WC; Qu X; Sun Y; Abdelkarim H; Le J; Saqib U; Sun MY; Kruse K; Banerjee A; Hitchinson B; Geyer M; Huang F; Guaiquil V; Mutso AA; Sanders M; Rosenblatt MI; Maienschein-Cline M; Lawrence MS; Gaponenko V; Malik AB; Komarova YA
    Cell Rep Med; 2023 Oct; 4(10):101223. PubMed ID: 37794584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiopoietin-1 suppresses choroidal neovascularization and vascular leakage.
    Lee J; Park DY; Park DY; Park I; Chang W; Nakaoka Y; Komuro I; Yoo OJ; Koh GY
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2191-9. PubMed ID: 24609620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models.
    Giddabasappa A; Lalwani K; Norberg R; Gukasyan HJ; Paterson D; Schachar RA; Rittenhouse K; Klamerus K; Mosyak L; Eswaraka J
    Exp Eye Res; 2016 Apr; 145():373-379. PubMed ID: 26927930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brivanib, a multitargeted small-molecule tyrosine kinase inhibitor, suppresses laser-induced CNV in a mouse model of neovascular AMD.
    Li L; Zhu M; Wu W; Qin B; Gu J; Tu Y; Chen J; Liu D; Shi Y; Liu X; Sang A; Ding D
    J Cell Physiol; 2020 Feb; 235(2):1259-1273. PubMed ID: 31270802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
    Lee JY; Chung H; Kim HC
    Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model.
    Kim SY; Kambhampati SP; Bhutto IA; McLeod DS; Lutty GA; Kannan RM
    Exp Eye Res; 2021 Feb; 203():108391. PubMed ID: 33307075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization.
    Song JH; Moon KY; Lee SC; Kim SS
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.
    Qiu F; Matlock G; Chen Q; Zhou K; Du Y; Wang X; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5065-5075. PubMed ID: 28980001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CXCR4 inhibition in the prevention and intervention model of laser-induced choroidal neovascularization.
    Lee E; Rewolinski D
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3666-72. PubMed ID: 20042641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of RACK1 ameliorates choroidal neovascularization formation in vitro and in vivo.
    Liu X; Zhu M; Yang X; Wang Y; Qin B; Cui C; Chen H; Sang A
    Exp Mol Pathol; 2016 Jun; 100(3):451-9. PubMed ID: 27112838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.